HDAC9 and thymic carcinoma: Therefore, the HDAC inhibitors targeting HDAC9 could be a promising treatment option for inoperable thymic carcinomas if the relevant role of HDAC9 in TECs and TETs, especially in the neuroendocrine lineage, is clarified.